Happy hypoxemia, or blunted ventilation?

COVID-19 Dyspnea Dyspnea descriptors Hypoxemia Respiratory drive

Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
06 01 2021
Historique:
received: 28 11 2020
accepted: 14 12 2020
entrez: 7 1 2021
pubmed: 8 1 2021
medline: 15 1 2021
Statut: epublish

Résumé

Happy hypoxemia is an unspecified definition that is used in COVID-19 patients to define hypoxemia without dyspnoea. Dyspnoea is a very complex symptom, and although hypoxemia can cause breathlessness, dyspnoea is not related to hypoxemia, but is more closely related to inspiratory drive and mechanical alterations. The lack of dyspnoea in the early stages of the disease is likely related to the absence of increased inspiratory drive due to compensatory mechanisms of hypoxemia, while in the advanced stages there is no evidence of a lack of dyspnoea in COVID-19 patients.

Identifiants

pubmed: 33407457
doi: 10.1186/s12931-020-01604-9
pii: 10.1186/s12931-020-01604-9
pmc: PMC7787398
doi:

Types de publication

Letter Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

4

Commentaires et corrections

Type : CommentOn
Type : CommentOn

Références

Am J Emerg Med. 2020 Oct;38(10):2243.e5-2243.e6
pubmed: 32471783
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Am J Respir Crit Care Med. 2012 Feb 15;185(4):435-52
pubmed: 22336677
J Med Virol. 2020 Nov;92(11):2272-2273
pubmed: 32530534
Science. 2020 May 1;368(6490):455-456
pubmed: 32355007
Respir Res. 2020 Jul 28;21(1):198
pubmed: 32723327
J Appl Physiol (1985). 1986 Sep;61(3):906-11
pubmed: 3759775
Respir Res. 2020 Sep 24;21(1):249
pubmed: 32972411
Am J Respir Crit Care Med. 2016 Feb 1;193(3):299-309
pubmed: 26407036
Am J Respir Crit Care Med. 2020 Aug 1;202(3):356-360
pubmed: 32539537
Neurol Sci. 2020 Oct;41(10):2671-2674
pubmed: 32734396
Eur J Neurol. 2020 Sep;27(9):e40
pubmed: 32301553
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264

Auteurs

Josuel Ora (J)

Division of Respiratory Medicine, University Hospital Policlinico Tor Vergata, Rome, Italy. josuel.ora@ptvonline.it.

Paola Rogliani (P)

Division of Respiratory Medicine, University Hospital Policlinico Tor Vergata, Rome, Italy.
Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.

Mario Dauri (M)

Department of Clinical Sciences and Translational Medicine, Tor Vergata University Hospital, Rome, Italy.

Denis O'Donnell (D)

Respiratory Investigation Unit, Department of Medicine, Queen's University, Kingston, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH